145 related articles for article (PubMed ID: 37751121)
21. Minimizing mosaicism: assessing the impact of fertilization method on rate of mosaicism after next-generation sequencing (NGS) preimplantation genetic testing for aneuploidy (PGT-A).
Palmerola KL; Vitez SF; Amrane S; Fischer CP; Forman EJ
J Assist Reprod Genet; 2019 Jan; 36(1):153-157. PubMed ID: 30362056
[TBL] [Abstract][Full Text] [Related]
22. Preimplantation genetic testing for BRCA gene mutation carriers: a cost effectiveness analysis.
Michaan N; Leshno M; Cohen Y; Safra T; Peleg-Hasson S; Laskov I; Grisaru D
Reprod Biol Endocrinol; 2021 Oct; 19(1):153. PubMed ID: 34620184
[TBL] [Abstract][Full Text] [Related]
23. Use of fertility treatments in BRCA1/2 mutation carriers and risk for ovarian and breast cancer: a systematic review.
Huber D; Seitz S; Kast K; Emons G; Ortmann O
Arch Gynecol Obstet; 2020 Sep; 302(3):715-720. PubMed ID: 32719921
[TBL] [Abstract][Full Text] [Related]
24. BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ.
Liu Y; Ide Y; Inuzuka M; Tazawa S; Kanada Y; Matsunaga Y; Kuwayama T; Sawada T; Akashi-Tanaka S; Nakamura S
Mol Genet Genomic Med; 2019 Mar; 7(3):e493. PubMed ID: 30652428
[TBL] [Abstract][Full Text] [Related]
25. Family planning in carriers of BRCA1 and BRCA2 pathogenic variants.
Haddad JM; Robison K; Beffa L; Laprise J; ScaliaWilbur J; Raker CA; Clark MA; Hofstatter E; Dalela D; Brown A; Bradford L; Toland M; Stuckey A
J Genet Couns; 2021 Dec; 30(6):1570-1581. PubMed ID: 33904624
[TBL] [Abstract][Full Text] [Related]
26. Fertility preservation in BRCA mutation carriers-efficacy and safety issues: a review.
Zhang X; Niu J; Che T; Zhu Y; Zhang H; Qu J
Reprod Biol Endocrinol; 2020 Feb; 18(1):11. PubMed ID: 32070378
[TBL] [Abstract][Full Text] [Related]
27. BRCA, infertility, and fertility preservation: a review for counseling.
Baltacı E; Kazancı F; Şahin Fİ
J Assist Reprod Genet; 2023 Mar; 40(3):465-472. PubMed ID: 36695945
[TBL] [Abstract][Full Text] [Related]
28. Outcomes of BRCA pre-implantation genetic testing according to the parental mutation origin: a cohort study.
Weizel I; Shavit T; Shuli Y; Adler Lazarovich C; Halevi R; Ben Ari T; Yaacobi-Artzi S; Bentov Y; Feldman B; Hershko Klement A
Reprod Biol Endocrinol; 2024 Jan; 22(1):8. PubMed ID: 38172815
[TBL] [Abstract][Full Text] [Related]
29. Awareness and attitude regarding reproductive options of persons carrying a BRCA mutation and their partners.
Gietel-Habets JJ; de Die-Smulders CE; Derks-Smeets IA; Tibben A; Tjan-Heijnen VC; van Golde R; Gomez-Garcia E; Kets CM; van Osch LA
Hum Reprod; 2017 Mar; 32(3):588-597. PubMed ID: 28073972
[TBL] [Abstract][Full Text] [Related]
30. Fertility preservation in patients with BRCA mutations or Lynch syndrome.
Corrado G; Marchetti C; Trozzi R; Scambia G; Fagotti A
Int J Gynecol Cancer; 2021 Mar; 31(3):332-338. PubMed ID: 33649002
[TBL] [Abstract][Full Text] [Related]
31. Uptake of Preimplantation Genetic Diagnosis in Female BRCA1 and BRCA2 Mutation Carriers.
Mor P; Brennenstuhl S; Metcalfe KA
J Genet Couns; 2018 Dec; 27(6):1386-1394. PubMed ID: 29858758
[TBL] [Abstract][Full Text] [Related]
32. Prognostic role of preimplantation genetic testing for aneuploidy in medically indicated fertility preservation.
Blakemore JK; Trawick EC; Grifo JA; Goldman KN
Fertil Steril; 2020 Feb; 113(2):408-416. PubMed ID: 31973902
[TBL] [Abstract][Full Text] [Related]
33. Reproductive Decision-Making in Women with BRCA1/2 Mutations.
Chan JL; Johnson LNC; Sammel MD; DiGiovanni L; Voong C; Domchek SM; Gracia CR
J Genet Couns; 2017 Jun; 26(3):594-603. PubMed ID: 27796678
[TBL] [Abstract][Full Text] [Related]
34. BRCA germline mutations in an unselected nationwide cohort of Chinese patients with ovarian cancer and healthy controls.
Li A; Xie R; Zhi Q; Deng Y; Wu Y; Li W; Yang L; Jiao Z; Luo J; Zi Y; Sun G; Zhang J; Shi Y; Liu J
Gynecol Oncol; 2018 Oct; 151(1):145-152. PubMed ID: 30078507
[TBL] [Abstract][Full Text] [Related]
35. Breast cancer, BRCA mutations, and attitudes regarding pregnancy and preimplantation genetic diagnosis.
Woodson AH; Muse KI; Lin H; Jackson M; Mattair DN; Schover L; Woodard T; McKenzie L; Theriault RL; Hortobágyi GN; Arun B; Peterson SK; Profato J; Litton JK
Oncologist; 2014 Aug; 19(8):797-804. PubMed ID: 24951607
[TBL] [Abstract][Full Text] [Related]
36. Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.
Kotsopoulos J; Lubinski J; Gronwald J; Cybulski C; Demsky R; Neuhausen SL; Kim-Sing C; Tung N; Friedman S; Senter L; Weitzel J; Karlan B; Moller P; Sun P; Narod SA;
Int J Cancer; 2015 Sep; 137(5):1136-46. PubMed ID: 25482078
[TBL] [Abstract][Full Text] [Related]
37. BRCA Mutations Increase Fertility in Families at Hereditary Breast/Ovarian Cancer Risk.
Kwiatkowski F; Arbre M; Bidet Y; Laquet C; Uhrhammer N; Bignon YJ
PLoS One; 2015; 10(6):e0127363. PubMed ID: 26047126
[TBL] [Abstract][Full Text] [Related]
38. Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations.
Phillips KA; Collins IM; Milne RL; McLachlan SA; Friedlander M; Hickey M; Stern C; Hopper JL; Fisher R; Kannemeyer G; Picken S; Smith CD; Kelsey TW; Anderson RA;
Hum Reprod; 2016 May; 31(5):1126-32. PubMed ID: 27094481
[TBL] [Abstract][Full Text] [Related]
39. Baseline and post prophylactic tubal-ovarian surgery CA125 levels in BRCA1 and BRCA2 mutation carriers.
Chen Y; Bancroft E; Ashley S; Arden-Jones A; Thomas S; Shanley S; Saya S; ; Wakeling E; Eeles R
Fam Cancer; 2014 Jun; 13(2):197-203. PubMed ID: 24389956
[TBL] [Abstract][Full Text] [Related]
40. [Should a systematic fertility preservation be proposed to healthy women carrying a BRCA1/2 mutation?].
Sénéchal C; Rousset-Jablonski C
Gynecol Obstet Fertil; 2015 Dec; 43(12):800-5. PubMed ID: 26476890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]